Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Colorectal Cancer Reports

Issue 3/2014

Content (15 Articles)

Erratum

Erratum to: Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same?

Maria Ignez Braghiroli, Rachel P. Riechelmann, Jorge Sabbaga, Paulo M. Hoff

INVITED COMMENTARY

To HIPEC or Not to HIPEC? That Is The Question

David P. Ryan

Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

Clinical End Points and Relevant Clinical Benefits in Advanced Colorectal Cancer Trials

Margarita García, Valentín Navarro, Ana Clopés

Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

Optimization of Anti-EGFR Treatment of Advanced Colorectal Cancer

Loredana Vecchione

Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

Optimization of Patient Selection for Surgical Approach to Peritoneal Metastases from Gastrointestinal Cancer Using Cytoreductive Surgery and Perioperative Chemotherapy

Paul H. Sugarbaker

Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

Optimization of the Development of Old and New EGFR and MAP Kinase Inhibitors for Colorectal Cancer

Erika Martinelli, Stefania Napolitano, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani

Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

New Targets and New Drug Development in Colorectal Cancer

Ana C. Garrido-Castro, Tamara Sauri-Nadal, Teresa Macarulla-Mercadé

Open Access Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

Pulmonary Metastasectomy for Colorectal Cancer: Recent Reports Prompt a Review of the Available Evidence

Tom Treasure

Therapeutic Approaches to Metastatic Colorectal Cancers (R Salazar, Section Editor)

Oxaliplatin Neurotoxicity

Roser Velasco, Jordi Bruna

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Adjuvant HIPEC in Colorectal Cancer

Dominique Élias, Alexis-Simon Cloutier, Fabrizio Vittadello, Charles Honoré, Frédéric Dumont, Diane Goéré

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Update on the Colon Health and Life-Long Exercise Change Trial: A Phase III Study of the Impact of an Exercise Program on Disease-Free Survival in Colon Cancer Survivors

Kerry S. Courneya, Janette Vardy, Sharlene Gill, Derek Jonker, Patti O’Brien, Christine M. Friedenreich, Haryana Dhillon, Rebecca K. S. Wong, Ralph M. Meyer, Jennifer J. Crawford, Kristin L. Campbell, Harry Prapavessis, Christopher O’Callaghan, Jane Turner, Lissa M. Spencer, Hidde P. van der Ploeg, Dongsheng Tu, Christopher M. Booth

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Accuracy of Predefined Hypotheses in Colon Cancer Adjuvant Phase III Trials: Observations and Recommendations

Aimery de Gramont, Benoist Chibaudel, Nathalie Perez-Staub, Sarah Dumont, Annette K. Larsen, Thierry André

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Vitamin D for Prevention and Treatment of Colorectal Cancer: What is the Evidence?

Kimmie Ng

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Prognostic Impact of Deficient DNA Mismatch Repair and KRAS and BRAF V600E Mutations in Patients with Lymph-Node-Positive Colon Cancer

Aziz Zaanan, Jean-Baptiste Bachet, Thierry André, Frank A. Sinicrope

ADJUVANT THERAPY FOR COLON CANCERS (AB BENSON III AND A DE GRAMONT, SECTION EDITORS)

Adjuvant Therapy in Combination with Resection of Colorectal Cancer Metastasis to the Liver or Lungs

Antoine Brouquet, Bernard Nordlinger

Jun 14
Issue: 2/2014
Dec 14
Issue: 4/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits